Table of Contents
ISRN Nephrology
Volume 2014, Article ID 714081, 11 pages
http://dx.doi.org/10.1155/2014/714081
Research Article

Hyaluronan Is Not a Ligand but a Regulator of Toll-Like Receptor Signaling in Mesangial Cells: Role of Extracellular Matrix in Innate Immunity

Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV der LMU, Pettenkoferstr. 8a, 80336 Munich, Germany

Received 28 September 2013; Accepted 30 October 2013; Published 21 January 2014

Academic Editors: T. Doi, T. D. Hewitson, and M. Merta

Copyright © 2014 Rainer Ebid et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Meyer and J. Palmer, “The polysaccharide of the vitreous humor,” The Journal of Biological Chemistry, vol. 107, pp. 629–634, 1934. View at Google Scholar
  2. R. Stern, A. A. Asari, and K. N. Sugahara, “Hyaluronan fragments: an information-rich system,” European Journal of Cell Biology, vol. 85, no. 8, pp. 699–715, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Jiang, J. Liang, and P. W. Noble, “Hyaluronan as an immune regulator in human diseases,” Physiological Reviews, vol. 91, no. 1, pp. 221–264, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. K. A. Scheibner, M. A. Lutz, S. Boodoo, M. J. Fenton, J. D. Powell, and M. R. Horton, “Hyaluronan fragments act as an endogenous danger signal by engaging TLR2,” Journal of Immunology, vol. 177, no. 2, pp. 1272–1281, 2006. View at Google Scholar · View at Scopus
  5. K. Rilla, R. Tiihonen, A. Kultti, M. Tammi, and R. Tammi, “Pericellular hyaluronan coat visualized in live cells with a fluorescent probe is scaffolded by plasma membrane protrusions,” Journal of Histochemistry and Cytochemistry, vol. 56, no. 10, pp. 901–910, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Lesley, R. Hyman, N. English, J. B. Catterall, and G. A. Turner, “CD44 in inflammation and metastasis,” Glycoconjugate Journal, vol. 14, no. 5, pp. 611–622, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Šoltés, G. Kogan, M. Stankovská et al., “Degradation of high-molar-mass hyaluronan and characterization of fragments,” Biomacromolecules, vol. 8, no. 9, pp. 2697–2705, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Ragan and K. Meyer, “The hyaluronic acid of synovial fluid in rheumatoid arthritis,” The Journal of Clinical Investigation, vol. 28, no. 1, pp. 56–59, 1949. View at Google Scholar · View at Scopus
  9. A. Tezel and G. H. Fredrickson, “The science of hyaluronic acid dermal fillers,” Journal of Cosmetic and Laser Therapy, vol. 10, no. 1, pp. 35–42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. R. Gannon, “Clinical experiences with intravenous use of sodium hyaluronate in racing greyhounds,” Australian Veterinary Journal, vol. 76, no. 7, pp. 474–475, 1998. View at Google Scholar · View at Scopus
  11. C. E. Kawcak, D. D. Frisbie, G. W. Trotter et al., “Effects of intravenous administration of sodium hyaluronate on carpal joints in exercising horses after arthroscopic surgery and osteochondral fragmentation,” American Journal of Veterinary Research, vol. 58, no. 10, pp. 1132–1140, 1997. View at Google Scholar · View at Scopus
  12. C. Termeer, F. Benedix, J. Sleeman et al., “Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4,” Journal of Experimental Medicine, vol. 195, no. 1, pp. 99–111, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. O. Takeuchi and S. Akira, “Pattern Recognition Receptors and Inflammation,” Cell, vol. 140, no. 6, pp. 805–820, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Hoebe, X. Du, P. Georgel et al., “Identification of Lps2 as a key transducer of MyD88-independent TIR signalling,” Nature, vol. 424, no. 6950, pp. 743–748, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. R.-B. Yang, M. R. Mark, A. Gray et al., “Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling,” Nature, vol. 395, no. 6699, pp. 284–288, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. K. L. Rock, E. Latz, F. Ontiveros, and H. Kono, “The sterile inflammatory response,” Annual Review of Immunology, vol. 28, pp. 321–342, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. H.-J. Anders, “Toll-like receptors and danger signaling in kidney injury,” Journal of the American Society of Nephrology, vol. 21, no. 8, pp. 1270–1274, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. H. J. Anders and D. Schlondorff, “Toll-like receptors: emerging concepts in kidney disease,” Current Opinion in Nephrology and Hypertension, vol. 16, pp. 177–183, 2007. View at Google Scholar
  19. H.-J. Anders and D. A. Muruve, “The inflammasomes in kidney disease,” Journal of the American Society of Nephrology, vol. 22, no. 6, pp. 1007–1018, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. H.-J. Anders, “Innate pathogen recognition in the kidney: toll-like receptors, NOD-like receptors, and RIG-like helicases,” Kidney International, vol. 72, no. 9, pp. 1051–1056, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. H.-J. Anders, B. Banas, Y. Linde et al., “Bacterial CpG-DNA aggravates immune complex glomerulonephritis: role of TLR9-mediated expression of chemokines and chemokine receptors,” Journal of the American Society of Nephrology, vol. 14, no. 2, pp. 317–326, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. H.-J. Anders, V. Vielhauer, V. Eis et al., “Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice,” The FASEB Journal, vol. 18, no. 3, pp. 534–536, 2004. View at Google Scholar · View at Scopus
  23. R. D. Pawar, P. S. Patole, A. Ellwart et al., “Ligands to nucleic acid-specific toll-like receptors and the onset of lupus nephritis,” Journal of the American Society of Nephrology, vol. 17, no. 12, pp. 3365–3373, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. R. D. Pawar, P. S. Patole, D. Zecher et al., “Toll-like receptor-7 modulates immune complex glomerulonephritis,” Journal of the American Society of Nephrology, vol. 17, no. 1, pp. 141–149, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. P. S. Patole, R. D. Pawar, M. Lech et al., “Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice,” Nephrology Dialysis Transplantation, vol. 21, no. 11, pp. 3062–3073, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. P. S. Patole, H.-J. Gröne, S. Segerer et al., “Viral double-stranded RNA aggravates lupus nephritis through toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells,” Journal of the American Society of Nephrology, vol. 16, no. 5, pp. 1326–1338, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. P. S. Patole, R. D. Pawar, J. Lichtnekert et al., “Coactivation of Toll-like receptor-3 and -7 in immune complex glomerulonephritis,” Journal of Autoimmunity, vol. 29, no. 1, pp. 52–59, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. P. S. Patole, S. Schubert, K. Hildinger et al., “Toll-like receptor-4: Renal cells and bone marrow cells signal for neutrophil recruitment during pyelonephritis,” Kidney International, vol. 68, no. 6, pp. 2582–2587, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. R. D. Pawar, L. Castrezana-Lopez, R. Allam et al., “Bacterial lipopeptide triggers massive albuminuria in murine lupus nephritis by activating Toll-like receptor 2 at the glomerular filtration barrier,” Immunology, vol. 128, no. 1, pp. e206–e221, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Lichtnekert, V. Vielhauer, D. Zecher et al., “Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/Trif,” American Journal of Physiology, vol. 296, no. 4, pp. F867–F874, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. J. B. Foidart, Y. S. Pirard, R. J. Winand, and P. R. Mahieu, “Tissue culture of normal rat glomeruli. Glycosaminoglycan biosynthesis by homogeneous epithelial and mesangial cell populations,” Renal Physiology, vol. 3, no. 1–6, pp. 169–173, 1980. View at Google Scholar · View at Scopus
  32. W. W. C. van Maren, S. Nierkens, L. W. Toonen, J. M. Bolscher, R. P. M. Sutmuller, and G. J. Adema, “Multifaceted effects of synthetic TLR2 ligand and Legionella pneumophilia on Treg-mediated suppression of T cell activation,” BMC Immunology, vol. 12, article 23, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. H. J. Brown, H. R. Lock, S. H. Sacks, and M. G. Robson, “TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis,” The Journal of Immunology, vol. 177, pp. 1925–1931, 2006. View at Google Scholar
  34. A. Kumar, J. Zhang, and F.-S. X. Yu, “Toll-like receptor 3 agonist poly(I:C)-induced antiviral response in human corneal epithelial cells,” Immunology, vol. 117, no. 1, pp. 11–21, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. B. J. Lim, D. Lee, S. W. Hong, and H. J. Jeong, “Toll-like receptor 4 signaling is involved in IgA-stimulated mesangial cell activation,” Yonsei Medical Journal, vol. 52, no. 4, pp. 610–615, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Kwon, A. T. Gewirtz, D. J. Hurley, T. P. Robertson, J. N. Moore, and M. L. Vandenplas, “Disparities in TLR5 expression and responsiveness to flagellin in equine neutrophils and mononuclear phagocytes,” Journal of Immunology, vol. 186, no. 11, pp. 6263–6270, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. J. R. Warren, “Polymyxin B suppresses the endotoxin inhibition of concanavalin A-mediated erythrocyte agglutination,” Infection and Immunity, vol. 35, no. 2, pp. 594–599, 1982. View at Google Scholar · View at Scopus
  38. L. Wang, J. R. Brown, A. Varki, and J. D. Esko, “Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins,” Journal of Clinical Investigation, vol. 110, no. 1, pp. 127–136, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. D. McClean, “The in vivo decapsulation of streptococci by hyaloronidase,” The Journal of Pathology and Bacteriology, vol. 54, article 284, 1942. View at Google Scholar
  40. U. Ohto, K. Fukase, K. Miyake, and T. Shimizu, “Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2,” Proceedings of the National Academy of Sciences of USA, vol. 109, pp. 7421–7426, 2012. View at Google Scholar
  41. A. A. Lugade, A. Bianchi-Smiraglia, V. Pradhan, G. Elkin, T. F. Murphy, and Y. Thanavala, “Lipid motif of a bacterial antigen mediates immune responses via TLR2 signaling,” PLoS ONE, vol. 6, no. 5, article e19781, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Yung, R. C. W. Tsang, J. K. H. Leung, and T. M. Chan, “Increased mesangial cell hyaluronan expression in lupus nephritis is mediated by anti-DNA antibody-induced IL-1β,” Kidney International, vol. 69, no. 2, pp. 272–280, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. T. P. King and K. M. Wittkowski, “Hyaluronidase and hyaluronan in insect venom allergy,” International Archives of Allergy and Immunology, vol. 156, no. 2, pp. 205–211, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Muto, K. Yamasaki, K. R. Taylor, and R. L. Gallo, “Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPS,” Molecular Immunology, vol. 47, no. 2-3, pp. 449–456, 2009. View at Publisher · View at Google Scholar · View at Scopus